Oslo University Hospital
Oslo University Hospital
Oslo, Oslo, Norway7 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Prospective Natural History Study of POLG Disease | Chronic Disease, Disease Attributes, Dyskinesias, Neurologic Manifestations, Nutritional and Metabolic Diseases, Ocular Motility Disorders, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, atactic disorder, non-human animal, brain disorder, central nervous system disorder, cranial nerve neuropathy, epilepsy, eye disorder, inborn mitochondrial metabolism disorder, inborn mitochondrial myopathy, metabolic disease, muscle tissue disorder, musculoskeletal system disorder, nervous system disorder, neuromuscular disease, ophthalmoplegia, palsy, progressive external ophthalmoplegia, visual epilepsy | Recruiting | Not stated | 2026-09-15 | NCT07775872 | |
| DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection. | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, cholangiocarcinoma, epithelial neoplasm, hepatocellular carcinoma, hilar cholangiocarcinoma, liver cancer, liver disorder, neoplasm | Recruiting | Not stated | 2026-07-21 | NCT07717437 | |
| Retinopathy of Prematurity - Visual Function and Retinal Structure | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases and Pregnancy Complications, Infant, Newborn, Diseases, Infant, Premature, Diseases, Neurologic Manifestations, Obstetric Labor Complications, Obstetric Labor, Premature, Pathological Conditions, Signs and Symptoms, Premature Birth, Sensation Disorders, Signs and Symptoms, Urogenital Diseases, blindness (disorder), cortical blindness, eye disorder, nervous system disorder, pregnancy disorder, refractive error, retinal disorder, retinopathy of prematurity, vision disorder | Not yet recruiting | Not stated | 2026-02-23 | NCT07427719 | |
| MumCare: Mum's Cardiovascular Health for Life | Female Urogenital Diseases and Pregnancy Complications, Infections, Nutritional and Metabolic Diseases, Toxemia, Urogenital Diseases, cardiovascular disorder, diabetes mellitus, endocrine system disorder, gestational diabetes, glucose metabolism disease, hypertension, pregnancy-induced, hypertensive disorder, metabolic disease, preeclampsia, pregnancy disorder, vascular disorder | Enrolling by invitation | Not applicable | 2026-02-18 | NCT05835596 | |
| HAI-Floxuridine, or SIRT, Combined With Gemox For Patients With Intra-Hepatic Cholangiocarcinoma Not Amenable to Resection (TOMCAT) | Neoplasms by Histologic Type, adenocarcinoma, carcinoma, cholangiocarcinoma, epithelial neoplasm, intrahepatic cholangiocarcinoma, neoplasm | Recruiting | Phase 2 | 2026-02-02 | NCT06313203 | |
| Establishment of Molecular Profiling for Individual Clinical Routine Treatment Decision in Early Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Not stated | 2025-08-08 | NCT03904173 | |
| The NADAPT Study: a Randomized Double-blind Trial of NAD Replenishment Therapy for Atypical Parkinsonism | Neurologic Manifestations, Ocular Motility Disorders, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, autonomic nervous system disorder, basal ganglia disorder, brain disorder, central nervous system disorder, corticobasal degeneration disorder, cranial nerve neuropathy, eye disorder, movement disorder, multiple system atrophy, nervous system disorder, neurodegenerative disease, ophthalmoplegia, palsy, primary dysautonomia, progressive supranuclear palsy, synucleinopathy, tauopathy | Recruiting | Phase 2 | 2025-01-10 | NCT06162013 |